Inventor · disambiguated record
Cheng Liu
Also filed as: LIU CHENG · LIU CHENG-WEI
55 granted patents·33 pending applications·328 citations·filing 2004–2025
98Inventor score
Files withMEMORIAL SLOAN KETTERING CANCER CENTER35EUREKA THERAPEUTICS INC14INNOLUX CORP4NOVARTIS VACCINES & DIAGNOSTICS INC4LIU CHENG3
Top patents by PatentIndex Score
88 records- 0197US11000549B2Methods of using chimeric antigen receptors targeting B-cell maturation antigen and uses thereofMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2020·Granted May 11, 2021·6 cites·20 claims
- 0297US10906956B2Methods of treatments using chimeric antigen receptors targeting G-protein coupled receptorMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2020·Granted Feb 2, 2021·7 cites·20 claims
- 0397US10821135B2Nucleic acid molecules encoding chimeric antigen receptors targeting B-cell maturation antigen and uses thereofMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2020·Granted Nov 3, 2020·7 cites·30 claims
- 0496US10918665B2Chimeric antigen receptors targeting B-cell maturation antigen and uses thereofMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2017·Granted Feb 16, 2021·16 cites·57 claims
- 0596US9540448B2T cell receptor-like antibodies specific for a WTI peptide presented by HLA-A2MEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2015·Granted Jan 10, 2017·32 cites·10 claims
- 0695US11725059B2Antibodies targeting B-cell maturation antigen and methods of useMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2021·Granted Aug 15, 2023·3 cites·40 claims
- 0795US11155615B2Anti-ROR1 antibodiesFIVE PRIME THERAPEUTICS INC·Filed 2016·Granted Oct 26, 2021·13 cites·13 claims
- 0895US10822389B2Antibody/T-cell receptor chimeric constructs and uses thereofEUREKA THERAPEUTICS INC·Filed 2019·Granted Nov 3, 2020·11 cites·22 claims
- 0995US9074000B2T cell receptor-like antibodies specific for a WT1 peptide presented by HLA-A2SCHEINBERG DAVID A·Filed 2012·Granted Jul 7, 2015·39 cites·32 claims
- 1094US10562972B2Antibodies targeting B-cell maturation antigen and methods of useMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2017·Granted Feb 18, 2020·9 cites·67 claims
- 1194US10464988B2Antibody/T-cell receptor chimeric constructs and uses thereofEUREKA THERAPEUTICS INC·Filed 2018·Granted Nov 5, 2019·16 cites·18 claims
- 1294US10098951B2Antibody/T-cell receptor chimeric constructs and uses thereofEUREKA THERAPEUTICS INC·Filed 2017·Granted Oct 16, 2018·17 cites·46 claims
- 1393US10947314B2Antibodies targeting b-cell maturation antigen and methods of useMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2019·Granted Mar 16, 2021·5 cites·30 claims
- 1492US10011658B2Constructs targeting AFP peptide/MHC complexes and uses thereofEUREKA THERAPEUTICS INC·Filed 2017·Granted Jul 3, 2018·14 cites·24 claims
- 1591US10590196B2Antibodies targeting G-protein coupled receptor and methods of useMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2017·Granted Mar 17, 2020·10 cites·46 claims
- 1689US11868690B1Method, device, electronic equipment and medium for analyzing disaster prevention and mitigation effectiveness of ecological seawallPEARL RIVER WATER RESOURCES RES INSTITUTE·Filed 2023·Granted Jan 9, 2024·39 cites·9 claims
- 1789US9926371B2M-CSF specific monoclonal antibody and uses thereofNOVARTIS VACCINES & DIAGNOSTICS INC·Filed 2016·Granted Mar 27, 2018·7 cites·17 claims
- 1889US9079956B2M-CSF specific monoclonal antibody and uses thereofNOVARTIS VACCINES & DIAGNOSTIC·Filed 2014·Granted Jul 14, 2015·11 cites·30 claims
- 1988US11421013B2Antibody/T-cell receptor chimeric constructs and uses thereofEUREKA THERAPEUTICS INC·Filed 2016·Granted Aug 23, 2022·3 cites·20 claims
- 2088US11384144B2T cell receptor-like antibodies specific for a PRAME peptideMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2017·Granted Jul 12, 2022·3 cites·46 claims
- 2188US10633426B2Chimeric antigen receptors targeting G-protein coupled receptor and uses thereofMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2017·Granted Apr 28, 2020·5 cites·49 claims
- 2288US10239952B2Anti-WT1/HLA bi-specific antibodyMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2014·Granted Mar 26, 2019·8 cites·8 claims
- 2386US2024335475A1Methods of using chimeric antigen receptors targeting b-cell maturation antigen and uses thereofMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2024·Application pending·0 cites
- 2485US12176119B1Integrated rapid treatment system for nuclear medical radioactive wastewater and application method thereofUNIV SW SCI & TECH SWUST·Filed 2024·Granted Dec 24, 2024·2 cites·8 claims
- 2585US11566071B2Nucleic acid molecules encoding anti-GPRC5D antibodiesMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2019·Granted Jan 31, 2023·2 cites·35 claims
- 2685US10913796B2Antibodies targeting Fc receptor-like 5 and methods of useMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2018·Granted Feb 9, 2021·2 cites·44 claims
- 2785US8080415B2Modified host cells and uses thereofLIU CHENG·Filed 2009·Granted Dec 20, 2011·8 cites·11 claims
- 2885US8025879B2Modified glycoproteins and uses thereofEUREKA THERAPEUTICS INC·Filed 2009·Granted Sep 27, 2011·7 cites·6 claims
- 2984US11866478B2Nucleic acid molecules encoding chimeric antigen receptors targeting G-protein coupled receptorMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2020·Granted Jan 9, 2024·1 cites·40 claims
- 3084US11820806B2Chimeric antigen receptors targeting G-protein coupled receptor and uses thereofMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2020·Granted Nov 21, 2023·1 cites·50 claims
- 3184US10858444B2T cell receptor-like antibodies specific for a WTI peptide presented by HLA-A2MEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2018·Granted Dec 8, 2020·1 cites·10 claims
- 3284US2025059283A1Chimeric antigen receptors targeting fc receptor-like 5 and uses thereofMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2024·Application pending·0 cites
- 3382US11117964B2Anti-KIR3DL1 antibodiesMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2018·Granted Sep 14, 2021·4 cites·20 claims
- 3482US11059891B2Chimeric antigen receptors targeting Fc receptor-like 5 and uses thereofMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2017·Granted Jul 13, 2021·1 cites·63 claims
- 3580US10040865B2T cell receptor-like antibodies specific for a WTI peptide presented by HLA-A2MEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2016·Granted Aug 7, 2018·2 cites·20 claims
- 3680US8084222B2Methods for generating host cellsLIU CHENG·Filed 2009·Granted Dec 27, 2011·4 cites·13 claims
- 3779US12370782B2Manufacturing method of electronic deviceINNOLUX CORP·Filed 2024·Granted Jul 29, 2025·0 cites·8 claims
- 3879US2022348629A1Antibody/t-cell receptor chimeric constructs and uses thereofEUREKA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3979US2024076370A1Antibodies targeting g-protein coupled receptor and methods of useMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2022·Application pending·0 cites
- 4079US2025344504A1Nitride-based passivation layer at sige surface in nano-fetTAIWAN SEMICONDUCTOR MFG CO LTD·Filed 2025·Application pending·0 cites
- 4178US11242405B2Monoclonal antigen-binding proteins to intracellular oncogene productsMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2017·Granted Feb 8, 2022·1 cites·29 claims
- 4278US11136392B2PD-1 immune modulating agentsMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2017·Granted Oct 5, 2021·1 cites·36 claims
- 4378US2025361286A1Antibody/t-cell receptor chimeric constructs and uses thereofEUREKA THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 4475US11976105B2Antibody/T-cell receptor chimeric constructs and uses thereofEUREKA THERAPEUTICS INC·Filed 2021·Granted May 7, 2024·0 cites·20 claims
- 4574US2021163624A1T cell receptor-like antibodies specific for a wti peptide presented by hla-a2MEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2020·Application pending·0 cites
- 4674US2021346432A1Methods of using chimeric antigen receptors targeting b-cell maturation antigen and uses thereofMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2021·Application pending·0 cites
- 4773US11505599B2T cell receptor-like antibodies specific for Foxp3-derived peptidesMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2017·Granted Nov 22, 2022·1 cites·11 claims
- 4873US2025204036A1Nitride-based passivation layer at sige surface in nano-fetTAIWAN SEMICONDUCTOR MFG CO LTD·Filed 2024·Application pending·0 cites
- 4972US12139538B2Chimeric antigen receptors targeting Fc receptor-like 5 and uses thereofMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2021·Granted Nov 12, 2024·0 cites·31 claims
- 5072US9522186B2M-CSF specific monoclonal antibody and uses therofNOVARTIS VACCINES & DIAGNOSTICS INC·Filed 2015·Granted Dec 20, 2016·1 cites·22 claims
Showing the top 50 of 88 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Cheng Liu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →